Singapore, Singapore

Soh Ha Chan

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Agency for Science, Technology and Research, National University of Singapore. Active years: 2004-2016.

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2004-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Soh Ha Chan

Introduction

Soh Ha Chan is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and pharmaceutical compounds. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents is focused on a Hepatitis B virus specific antibody and its uses. This patent provides at least one isolated TCR-like antibody or fragment that is capable of specifically binding to at least one HBV derived peptide. Another significant patent involves novel phosphino-gold (I) compounds, detailing a process for their preparation, pharmaceutical compositions containing these compounds, and their use in the treatment of cancer diseases.

Career Highlights

Soh Ha Chan has worked with prominent institutions such as the Agency for Science, Technology and Research and the National University of Singapore. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in healthcare.

Collaborations

Throughout his career, Soh Ha Chan has collaborated with esteemed colleagues, including Antonio Bertoletti and Sastry Konduru Seetharama. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Soh Ha Chan's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in Singapore. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…